The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

S hould a high dividend yield raise a yellow flag for investors? In some cases, yes. But not always. There are select stocks ...

The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025. There are two other vaccines ...

With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.